产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 250mg | 99% | 现货 | |||
| 1g | 99% | 现货 | |||
| 5g | 99% | 现货 | |||
| 10g | 99% | 现货 | |||
| 25g | 99% | 现货 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 250mg | 99% | 现货 | |||
| 1g | 99% | 现货 | |||
| 5g | 99% | 现货 | |||
| 10g | 99% | 现货 | |||
| 25g | 99% | 现货 |
CAS No. |
27821-45-0 |
|---|---|
中文名称 |
((2R,3S,4R,5R)-5-(2,4-二氧代-3,4-二氢嘧啶-1(2H)-基)-3,4-二羟基四氢呋喃-2-基)甲基二膦酸二钠盐 |
英文名称 |
Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate |
别名 |
CCG-222509 | UDP disodium salt | AS-12237 | Uridine 5'-diphosphate disodium salt hyd | HMS3263B12 | SCHEMBL1873401 | A819204 | NCGC00261890-01 | AKOS015893509 | Disodium;[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidopho |
标准英文名 |
Sodium ((2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogen diphosphate |
MDL No. |
MFCD00149253 |
分子式 |
C9H12N2Na2O12P2 |
分子量 |
448.13 |
精确分子量 |
447.97 |
SMILES |
O[C@@H]([C@H]([C@H](N1C(NC(C=C1)=O)=O)O2)O)[C@H]2COP([O-])(OP([O-])(O)=O)=O.[Na+].[Na+] |
标准SMILES |
[Na+].[Na+].[O-]P(O)(=O)OP([O-])(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(=O)NC1=O |
性状 |
Form: powder Colour: white |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
ZQKVPFKBNNAXCE-WFIJOQBCSA-L |
危险类别(旧) |
H315,H319,H335 |
存储要求 |
Inert atmosphere,Store in freezer, under -20°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A),Specific target organ toxicity, single exposure; Respiratory tract irritation (Category 3) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|